Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
8.54
+0.44 (5.43%)
At close: Feb 21, 2025, 4:00 PM
8.96
+0.42 (4.92%)
After-hours: Feb 21, 2025, 6:54 PM EST
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $92.03 million as of February 21, 2025. Its market cap has increased by 152.14% in one year.
Market Cap
92.03M
Enterprise Value
92.07M
1-Year Change
152.14%
Ranking
Category
Stock Price
$8.54
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $92.03M, a decrease of -70.52%. That is a compound annual growth rate of -50.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 92.03M | 67.45% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |